GlassScriptPhysician profile
Gerry P Holland
NPI 1356381891
$8,285.50
in general payments reported to CMS, 2019-2025
15 companies · $601 in 2025
The $601 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,988 · 2020: $2,068 · 2021: $513 · 2022: $305 · 2023: $285 · 2024: $524 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,410.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $4,700.18 | 2019-2025 | Puraply, Apligraf, Affinity |
| Integra Lifesciences Corporation | $1,546.28 | 2019-2025 | Tcc-Ez |
| Kci USA, INC. | $667.06 | 2019-2023 | V.A.C. Dermatac, Activ.A.C. Ion Progress |
| Smith+Nephew, INC. | $531.95 | 2019-2025 | Collagenase Santyl |
| Solventum Corporation | $142.11 | 2024-2025 | Activ.A.C., Snap, Promogran Prisma |
| Next Science LLC | $140.85 | 2024 | Blastx, Surgx, Xperience |
| Paratek Pharmaceuticals, INC. | $112.79 | 2022 | |
| Medline Industries LP | $95.49 | 2024 | |
| Abbvie INC. | $75.99 | 2022 | |
| Convatec INC. | $75.97 | 2019-2025 | |
| Reprise Biomedical, INC. | $51.58 | 2025 | Miro3d |
| Hartmann USA, INC. | $48.06 | 2025 | Zetuvit Plus 10x10 P10 |
| Bsn Medical INC | $37.05 | 2025 | |
| Aroa Biosurgery Incorporated | $34.64 | 2020 | |
| Melinta Therapeutics, LLC | $25.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerry Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.